Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-02-20 12:57 Tx date 2024-12-31 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,309
+2,477 vol $1.74 each |
97,577 | |
Filed 2025-02-19 20:17 Tx date 2025-02-14 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$724,787
+220,300 vol $3.29 each |
1,100,800 | |
Filed 2025-02-19 20:16 Tx date 2025-02-14 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+54,300 vol |
138,067 | |
Filed 2025-02-05 17:39 Tx date 2025-02-04 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,206.239
-11,333 vol $3.28 each |
83,767 | |
Filed 2024-03-12 14:20 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$913,200
+380,500 vol $2.40 each |
880,500 | |
Filed 2024-03-12 14:17 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2024-03-12 14:12 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+95,100 vol |
95,100 | |
Filed 2024-03-12 13:57 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|